doi: 10.1186/1753-2000-2-24.
Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring
Affiliations
- PMID: 18793403
- PMCID: PMC2566553
- DOI: 10.1186/1753-2000-2-24
Item in Clipboard
Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring
Child Adolesc Psychiatry Ment Health.
.
Abstract
The review presents pediatric adverse drug events from a historical perspective and focuses on selected safety issues associated with off-label use of medications for the psychiatric treatment of youth. Clinical monitoring procedures for major psychotropic drug classes are reviewed. Prior studies suggest that systematic treatment monitoring is warranted so as to both minimize risk of unexpected adverse events and exposures to ineffective treatments. Clinical trials to establish the efficacy and safety of drugs currently being used off-label in the pediatric population are needed. In the meantime, clinicians should consider the existing evidence-base for these drugs and institute close clinical monitoring.
Similar articles
-
BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents.J Psychopharmacol. 2016 May;30(5):416-21. doi: 10.1177/0269881116636107. J Psychopharmacol. 2016. PMID: 27098018
-
Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children's Hospital.Front Pharmacol. 2022 Apr 12;13:837692. doi: 10.3389/fphar.2022.837692. eCollection 2022. Front Pharmacol. 2022. PMID: 35496268 Free PMC article.
-
Pediatric Off-Label and Unlicensed Drug Use and Its Implications.Curr Clin Pharmacol. 2017;12(1):18-25. doi: 10.2174/1574884712666170317161935. Curr Clin Pharmacol. 2017. PMID: 28322168 Review.
-
Off-label Medications Use in the Eastern Province of Saudi Arabia: The Views of General Practitioners, Pediatricians, and Other Specialists.Hosp Pharm. 2020 Feb;55(1):37-43. doi: 10.1177/0018578718817861. Epub 2018 Dec 7. Hosp Pharm. 2020. PMID: 31983765 Free PMC article.
-
Psychopharmacology in pediatric critical care.Child Adolesc Psychiatr Clin N Am. 2006 Jul;15(3):611-55. doi: 10.1016/j.chc.2006.02.005. Child Adolesc Psychiatr Clin N Am. 2006. PMID: 16797442 Review.
Cited by
-
Reforming Paediatric Drug Regulations in Canada: A Clinical and an Access Imperative.Healthc Policy. 2023 Aug;19(1):54-64. doi: 10.12927/hcpol.2023.27157. Healthc Policy. 2023. PMID: 37695707 Free PMC article.
-
Off-label use of psychotropic drugs in youth.BMC Psychiatry. 2025 Jul 30;25(1):739. doi: 10.1186/s12888-025-07176-6. BMC Psychiatry. 2025. PMID: 40739649 Free PMC article.
-
Pediatric Bipolar Disorder: Subtype Trend and Impact of Behavioral Comorbidities.J Clin Med. 2014 Mar 20;3(1):310-22. doi: 10.3390/jcm3010310. J Clin Med. 2014. PMID: 26237263 Free PMC article.
-
Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.Psychopharmacology (Berl). 2014 Apr;231(8):1479-92. doi: 10.1007/s00213-014-3434-4. Epub 2014 Jan 23. Psychopharmacology (Berl). 2014. PMID: 24452697 Free PMC article.
-
Combination and switching of stimulants in children and adolescents with attention deficit/hyperactivity disorder in quebec.J Can Acad Child Adolesc Psychiatry. 2014 Sep;23(3):157-66. J Can Acad Child Adolesc Psychiatry. 2014. PMID: 25320609 Free PMC article.
References
-
- Turner S, Nunn AJ, Choonara I. Unlicensed drug use in children in the UK. The International Journal of Pharmacy. 2004. http://www.priory.com/pharmol/uduiciuk.htm
-
- Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. 17. Elsevier Science; 2003.
-
- Brunton LL, Lazo JS, Parker KL. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11. The McGraw-Hill Companies; 2006.
LinkOut - more resources
Full Text Sources
